H11

Official title: Very early FDG-PET/CT-response adapted therapy for advanced stage Hodgkin's lymphoma, a randomized phase III non-inferiority study of the EORTC Lymphoma Group. Prematurely terminated

Trial start year: 2013

Trial website

No website available

Trial registration

NCT01652261
View registration
Design paper

Design paper

2012

Very early FDG-PET/CT-response adapted therapy for advanced stage Hodgkin Lymphoma (H11), a randomized phase III non-inferiority study of the EORTC Lymphoma Group and the Polish Lymphoma Research Group.
Download full paper

Result paper

No result paper published